Silver Book Fact

If the progression of Parkinson’s disease were slowed by 50%, there would be a 35% reduction in excess costs.

Johnson, SJ, MD Diener, A Kaltenboeck, HG Binbaum, and AD Siderowf. An Economic Model of Parkinson’s Disease: Implications for slowing progression in the United States. Mov Disord. 2013; http://www.ncbi.nlm.nih.gov/pubmed/23404374

Reference

Title
An Economic Model of Parkinson’s Disease: Implications for slowing progression in the United States
Publication
Mov Disord
Publication Date
2013
Authors
Johnson, SJ, MD Diener, A Kaltenboeck, HG Binbaum, and AD Siderowf
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Donepezil, a cholinesterase inhibitor, has been found to slow progression of Alzheimer’s disease in its early stages, delaying the need for nursing home care by an average of 30 months.  
  • Use of existing or new drugs/compounds for Alzheimer’s prevention could result in a delay of onset of between 2 and 5 years.  
  • Studies by the National Center for Complementary and Alternative Medicine (NCCAM) at NIH are looking at the neuroprotective qualities of diets rich in B vitamins and antioxidant phytochemicals. These nutrients…  
  • Delaying the onset of Alzheimer’s by only 5 years could reduce the number of people with Alzheimer’s by almost 50% after 50 years.  
  • The U.S. Food and Drug Administration has approved five drugs that temporarily improve Alzheimer’s disease symptoms.